Kenox Pharmaceuticals Adds Small-Scale GMP Capabilities for Nasal and Inhaled Drugs

  • Kenox Pharmaceuticals Inc. has added small-scale non-sterile GMP capabilities to support GLP preclinical studies for Orally Inhaled and Nasal Drug Products (OINDPs).
  • The expansion includes a clean room for compounding, fill-finish, and release of nasal sprays and dry powders, with further plans to enable small-scale GMP batch manufacturing for Phase I and II clinical trials.

Kenox Pharmaceuticals Inc. has expanded its drug development services by introducing small-scale non-sterile GMP capabilities to support GLP preclinical studies. The company, focused on Orally Inhaled and Nasal Drug Products (OINDPs), aims to accelerate drug development by providing a streamlined path from molecule to clinic.

The expansion includes a clean room facility for compounding, fill-finish, and release of non-sterile nasal sprays and dry powders. Additionally, Kenox Pharmaceuticals is planning further enhancements to support small-scale GMP batch manufacturing for Phase I and II clinical trials of both sterile and non-sterile OINDPs. This move is designed to reduce development risks and provide a comprehensive solution for pharmaceutical partners.

“I’m so excited about this expansion which was executed in a timely manner. This would not have been possible without our talented and capable team, rockstar QA, support from our partners/clients, various vendors, and the facility management,” said Sitaram Velaga, Founder, President and CEO at Kenox Pharmaceuticals Inc. “This expansion reflects our dedication to support our partners in their mission to develop cutting-edge therapeutics for unmet medical needs with meticulous attention to quality, efficiency, project goals, and timelines.”

With these new capabilities, Kenox Pharmaceuticals is positioned to support a variety of OINDP dosage forms across multiple therapeutic areas, including cardiology, psychiatry, antimicrobial/antiviral treatments, pain management, and rare diseases.

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.